Deficiency in the protein-tyrosine phosphatase SHP1/PTPN6 is linked with chronic inflammatory diseases and hematological malignancies in humans. Here we exploited the embryonic and larval stages of zebrafish (Danio rerio) as an animal model to study ptpn6 function in the sole context of innate immunity. We show that ptpn6 knockdown induces a spontaneous inflammation-associated phenotype at the late larval stage. Surprisingly, glucocorticoid treatment did not suppress inflammation under ptpn6 knockdown conditions but further enhanced leukocyte infiltration and proinflammatory gene expression. Experiments in a germ-free environment showed that the late larval phenotype was microbe independent. When ptpn6 knockdown embryos were challenged with Salmonella typhimurium or Mycobacterium marinum at earlier stages of development, the innate immune system was hyperactivated to a contraproductive level that impaired the control of these pathogenic bacteria. Transcriptome analysis demonstrated that KEGG pathways related to pathogen recognition and cytokine signaling were significantly enriched under these conditions, indicating that ptpn6 functions as a negative regulator that imposes a tight control over the level of innate immune response activation during infection. In contrast to the hyperinduction of pro-inflammatory cytokine genes under ptpn6 knockdown conditions, antiinflammatory il10 expression was not hyperinduced. These results demonstrate that ptpn6 has a crucial regulatory function in preventing host-detrimental effects of inflammation and is essential for a successful defense mechanism against invading microbes.
Introduction
The innate immune system has been conserved in evolution from invertebrate to vertebrate organisms and plays an indispensable role in host protection against infections. The vertebrate innate immune system has been demonstrated to not only function as the first line of defense against microorganisms, but also to be required for activating the secondary adaptive defenses. However, if the innate immune system goes unchecked, the production of inflammatory mediators can cause considerable tissue damage. Recent studies indicate that defects in the initial sensing of microorganisms and allergens by the innate immune system can contribute to autoimmune and autoinflammatory diseases, which were classically viewed as specific disorders of the adaptive immune system (Beutler, 2009; Drexler and Foxwell, 2010; Theofilopoulos et al., 2011) . In healthy individuals the innate immune response is tightly controlled by complex regulatory mechanisms that prevent excessive and chronic inflammation (O'Neill, 2008) . The SHP1 phosphatase, encoded by the PTPN6 gene, has been recognized as a critical factor in this process of negative regulation.
SHP1 belongs to the family of protein-tyrosine phosphatases (PTPs), which dephosphorylate phosphotyrosyl residues in proteins that are phosphorylated by protein-tyrosine kinases (PTKs). PTPs and PTKs function in a variety of cellular processes, from cell survival to proliferation, differentiation, migration and immune responses. SHP1 (PTPN6) and SHP2 (PTPN11) are closely related non-receptor type PTPs, each having two Src homology 2 (SH2) domains amino-terminal to the phosphatase catalytic domain (Zhang et al., 2000; Tsui et al., 2006; Pao et al, 2007) . While SHP2 is expressed ubiquitously, SHP1 is predominantly expressed in hematopoietic cell lineages, and it has been implicated in the regulation of a diverse range of cytokine receptors, growth factor receptors, and immunoreceptors. SHP1 has been shown to associate with immunoreceptor tyrosine-based inhibition motifs (ITIMs) in these receptors (Zhang et al., 2000; Tsui et al., 2006) , and has been proposed to bind to ITIM-like motifs in various kinases, including IRAK1, ERK1/2, p38, JNK, JAK2, JAK3, TAK1, IKKα, and LYN (Abu-Dayyeh et al., 2008; Abu-Dayyeh et al., 2010) .
SHP1 has been extensively studied after the discovery of two naturally occurring mutant mouse strains: motheaten (me), considered to carry a null allele of the Ptpn6 gene, and motheaten viable (mev), which encodes a phosphatase with approximately 20% of wild type catalytic activity (Shultz et al., 1993; Tsui et al., 1993; Kozlowski et al., 1993) . These mice suffer from severe immune disorders, with spontaneous inflammatory activity affecting multiple organs, including the lungs, kidney, joints, and skin, the latter resulting in their typical 'motheaten' appearance. The mutations result in lethal pneumonitis by three (me) or nine (mev) weeks of age. Backcrossing of mev mice to rag1 null mutants (that do not contain mature T and B cells) did not alleviate the motheaten inflammatory disease, indicating that the function of myeloid cells rather than the function of the adaptive immune system is required for major aspects of the shp1 mutant phenotype (Yu et al., 1996) . Furthermore, pulmonary inflammation in mev mutants was found to depend strongly on the function of mast cells . A viable hypomorphic allele of Ptpn6, spin (spontaneous inflammation), carrying a point mutation in one of the SH2 domains, was later described that elicits chronic inflammatory and autoimmune disease (Croker et al., 2008) . Inflammation in spin mutants was triggered by the presence of microbes and found dependent on production of IL-1, subsequent IL-1 signaling, and the presence of neutrophils (Croker et al., 2008; Croker et al., 2011) . Consistent with these findings, SHP1 was shown to negatively regulate Toll-like receptor (TLR)-mediated production of pro-inflammatory cytokines by suppressing the activation of MAPKs and the transcription factor NF-κB .
SHP1 has been associated with several human inflammatory diseases. In patients with psoriatic inflammatory skin disease, deficient SHP1 expression in T-cells has been observed (Eriksen et al., 2010) . Furthermore, macrophages of multiple sclerosis (MS) patients display SHP1 deficiency concomitant with enhanced expression of genes mediating inflammatory demyelination in MS pathogenesis (Christophi et al., 2009) . Finally, it has been suggested that altered expression of SHP1 may also be associated with human allergies and asthmatic disease, based on recent studies in mice that indicate a role of SHP1 in mast cells and allergic inflammatory responses . In addition, SHP1 is considered a putative tumor suppressor. Decreased expression of SHP1 has been observed in many types of human lymphomas and leukemias. The reduced levels of SHP1 in these malignancies have been attributed to mutations, epigenetic regulation, and post-transcriptional mechanisms (Wu et al., 2003; Witkiewicz et al., 2007) . SHP1 has also been implicated as a negative regulator of insulin signaling and clearance of insulin in the liver, and has been linked to progression of diabetic retinopathy (Dubois et al., 2006; Geraldes et al., 2009) .
As many recent studies have shown, the zebrafish embryo model has specific advantages not only for developmental biology but also for studying immunity, inflammation and infections (Lieschke and Trede, 2009; Martin and Renshaw, 2009; Meijer and Spaink, 2011) . The embryo model is particularly useful for studying responses of the innate immune system, as macrophages and neutrophils develop during the first two days of embryogenesis, when the adaptive immune system is not yet in place (Lam et al., 2004) . The zebrafish genome encodes orthologs of the majority of human PTPs, including shp1/ptpn6 and shp2/ptpn11a (van Eekelen et al., 2010) . We have previously shown that hematopoietic expression of shp1/ptpn6 is conserved in zebrafish embryos and controlled by the transcription factor Pu.1 (Spi1), like its human counterpart Wlodarski et al., 2007) . The zebrafish embryo model was also exploited to study the role of shp2 in early development and to investigate the cell biological effects of activating and inactivating mutations in Shp2 protein that underlie the Noonan and LEOPARD syndromes in humans. Defective Shp2 signaling induced cell movement defects as early as gastrulation and zebrafish embryos expressing Noonan or LEOPARD Shp2 displayed craniofacial and cardiac defects, reminiscent of human symptoms (Jopling et al., 2007) .
Here we used morpholino knockdown to study the effect of ptpn6 deficiency in zebrafish embryos. No visible phenotypic effects of ptpn6 knockdown were observed during early development, but morphant larvae developed a late phenotype at 5 to 6 days post fertilization (dpf). Skin lesions in these morphants were reminiscent of phenotypes of the murine ptpn6 mutants, motheaten and spin, which suffer from severe inflammation leading to patches of hair loss and foot lesions, as discussed above (Tsui et al., 1993; Croker et al., 2008) . Based on leukocyte infiltration and pro-inflammatory gene expression we concluded that also the zebrafish ptpn6 morphant phenotype is associated with an inflammatory response. We describe infection experiments of ptpn6 morphants with bacterial pathogens at 1 dpf, which is several days prior to the manifestation of the late inflammation-associated phenotype. We observed that ptpn6 morphants responded to bacterial challenge with increased induction of proinflammatory genes compared to wild type embryos, yet their ability to control these infections was severely impaired, indicating that this is not a functional response. In conclusion, our data demonstrate the role of ptpn6 as a negative regulator of the innate immune system, which is important for a functional innate immune response during bacterial infections.
Materials and methods

Zebrafish husbandry
Zebrafish were handled in compliance with the local animal welfare regulations and maintained according to standard protocols (zfin.org). Zebrafish lines used in this study included AB/TL, Tg(mpx:gfp)i114 (Renshaw et al., 2006) , Tg(fli1:EGFP) (Lawson and Weinstein, 2002) and Tg Tg(prl:RFP) zf113 (Liu et al., 2006) . Embryos were grown at 28.5-30°C in egg water (60 μg/ml Instant Ocean sea salts). For the duration of bacterial injections embryos were kept under anesthesia in egg water containing 200 µg/mL tricaine (Sigma-Aldrich). Embryos used for whole mount in situ hybridization and immunostaining were kept in egg water containing 0.003% 1-phenyl-2-thiourea (Sigma-Aldrich) to prevent melanization.
Morpholino knockdown
Morpholino oligonucleotides (Gene Tools) were diluted to the desired concentration in 1× Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM HEPES; pH 7.6) containing 1% phenol red (Sigma-Aldrich) and approximately 1 nL was injected at the 1-2 cell stage using a Femtojet injector (Eppendorf). For knockdown of ptpn6 two morpholinos were used, one targeting the exon 11/intron 11-12 splice junction (MO1: 5'ACTCATTCCTTACCCGATGCGGAGC3'; 0.0625 mM), and one targeting the translation start site (MO2: 5'CTGTGAAACCACCGAACCATCTTCC3'; 0.20 mM). As a control we used the standard control (SC) morpholino from GeneTools at the same concentrations as the ptpn6 MOs.
Whole-mount in situ hybridization, immunodetection, TUNEL assay, and myeloperoxidase activity assay For all assays embryos were fixed in 4% paraformaldehyde (PFA) in phosphatebuffered saline (PBS). Whole-mount in situ hybridization (WISH) using alkaline phosphatase detection with BM Purple substrate (Roche Diagnostics) was carried out as previously described (Stockhammer et al., 2009 ). Digoxigenin-labeled mfap4 and mpx probes were generated as described in . Immunofluorescence stainings were performed with 1:500 dilutions of polyclonal rabbit Ab against phospho-Histone H3 (Santa Cruz) and L-plastin (Mathias et al., 2007) . For detection, Alexa Fluor 568/488 goat anti-rabbit IgG secondary Ab (Molecular Probes) as described in (Cui et al., 2011) were used. DNA fragmentation during apoptotic cell death was examined by TUNEL using the ApopTag Peroxidase In Situ Apoptosis Detection Kit (Millipore) according to the manufacturer's instructions. Embryos were fixed, permeabilized, treated with Proteinase K and refixed in 4% PFA as for WISH. Embryos were then fixed in ethanol:acetic acid 2:1 for 15 min at -20ºC followed by PBS washes. After 15 min incubation in the equilibration buffer embryos were transferred to working strength TdT enzyme solution supplemented with 0.3% TritonX-100, and incubated for 1 h on ice followed by 1 h at 37ºC. The reaction was stopped by a 5 min wash in stop solution at room temperature, followed by 45 min incubation at 37ºC and PBS washes. Subsequent immunodetection with alkaline phosphatase-conjugated anti-DIG Fab fragments and BM purple staining was performed as for WISH. Histochemical staining for Mpx activity was performed with the Peroxidase Leukocyte Kit (Sigma-Aldrich) as described in (Cui et al., 2011) .
RNA isolation, quantitative RT-PCR, and RT-MLPA
RNA isolation and quantitative RT-PCR (qPCR) analysis was performed as described in (Stockhammer et al., 2009) . Primer sequences for ppial, il1b, mmp9, lgals, mpeg1, cxcr3.2, mfap4 , and marco are described in Stockhammer et al., 2009) . Additional primer sequences used were: lyz: FW5'TGTCCTCGTGTGAAAGCAAGAC3', REV5'AGAATCCCTCAAATCCATCAAGCC3'; mpx: FW5'AAGACAATGCACGAGAGC3', REV5'GCAATGAAGCAAGGAACC3'; csf1r: FW 5'CTGCTGGTCGTAGAGGAG3', REV 5'TGTGAAGTCAGAGGAGG3'; ncf1: FW5'CACAGGATGGCTGAAACATACG3, REV5'TAGTGCTGGCTGGGAAAGAATC3'. Reverse transcription -multiplex ligation-dependent probe amplification (RT-MLPA) was performed as described in (Rotman et al., 2011) .
Germ-free experiments
For generating germ-free embryos we used a natural breeding method described in (Pham et al., 2008) . Eggs were washed 3× in antibiotic gnotobiotic zebrafish medium (GZM) prior to performing morpholino injections in a down-flow cabinet using sterilized needles and equipment. Following injections, eggs were immediately washed with antibiotic GZM and were successively treated with PVP-I and bleach solutions. Embryos were grown in 6 well plates at 28°C wrapped in aluminum foil and sterile antibiotic GZM was refreshed daily. At the end of the experiment sterility was tested by plating media from the germ-free and conventionally raised embryos on tryptic soy agar plates.
Chemical treatments
Betamethasone 17-valerate (1 μM) , beclomethasone (25 μM), and prednisolone (25 μM) were dissolved in 0.1% DMSO and added directly to egg water at 1 dpf or 3 dpf, solutions were refreshed daily. Controls were treated with DMSO only. CuSO4-induced inflammation was performed as in (d'Alencon et al., 2010) .
Infection experiments
Salmonella typhimurium infections were performed using the S. typhimurium strain SL1027 and its isogenic LPS Ra mutant derivative SF1592, carrying the DsRed expression vector, pGMDs3 (van der Sar et al., 2003) . For Mycobacterium marinum infection experiments the Mma20 strain was used expressing mCherry in pSMT3 vector (van der Sar et al., 2004) . Bacteria were grown and prepared for injections as described in (Cui et al., 2011) , and microinjected into the caudal vein of embryos at 28 hours post fertilization (hpf), using a dose of 200-250 CFUs of S. typhimurium or 100 CFU of M. marinum per embryo. After injections embryos were transferred to fresh egg water and incubated at 28°C. For plating assays, infected embryos were homogenized using a Retsch mixer mill with a metal bead for 1 min at maximum speed.
Microarray analysis
For microarray analysis of S. typhimurium infection in ptpn6 morphants, three independent infection experiments were performed. In each experiment, RNA was isolated from pools of 15-20 embryos per treatment group. Knockdown of ptpn6 was performed using MO1 and control embryos were injected with Danieau buffer/phenol red. The ptpn6 morphants and control embryos were infected at 28 hpf with S. typhimurium SL1027 bacteria, or mock-injected with PBS as a control. RNA extraction was performed at 8 hpi. Microarray analysis was performed using a previously described custom-designed 44K Agilent chip (Agilent Technologies) (Stockhammer et al., 2009 ). All RNA samples were labeled with Cy5 and hybridized against a Cy3-labeled common reference, which consisted of a mixture of all samples from the infection study. Labeling, hybridization and data analysis using Rosetta Resolver 7.0 was performed as previously described (Stockhammer et al., 2009 ). The raw data were submitted to the Gene Expression Omnibus database under accession no. GSE34930. KEGG pathway analysis was performed using DAVID v6.7 (http://david.abcc.ncifcrf.gov/home.jsp) (Huang da et al., 2009 ).
Microscopy and image analysis
Bright field images of embryos were obtained with a Leica M165C stereomicroscope equipped with a DFC420C digital color camera ( Pixel counts on stereo fluorescence images were performed as described in (Stoop et al., 2011) .
Results
Knockdown of ptpn6 causes a late phenotype in zebrafish larvae that is characterized by enhanced proliferation, apoptosis, and inflammation
In order to study the function of the ptpn6 gene in zebrafish, a knockdown study of this gene was performed using a splice blocking morpholino that causes deletion of the phosphatase catalytic domain (MO1) and a translation blocking morpholino (MO2) ( Supplementary Fig. S1 A, B) . Both morpholinos did not have strong effects on embryo morphology at 1-3 dpf, except that the heads and eyes of ptpn6 morphants were slightly smaller compared with the controls (Fig. 1 A, B , H, I; Fig. 2 ). Furthermore, L-plastin immunostaining, in situ hybridization with mfap4 and mpx markers, and Mpx activity assays demonstrated that macrophage and neutrophil numbers and the migratory responses of these cells towards injury were normal (Fig. 2) .
However, at later stages of development, pleiotropic effects on larval morphology were observed that became progressively severe. At 3 dpf, some embryos showed a minor oedema of the heart cavity ( Fig. 1 B, I ), which became more prominent at 4 dpf ( Fig. 1 C, J) . At 5-6 dpf, morphant larvae additionally developed lesions on the eyes and skin, and in severe cases they also developed oedema between the trunk and the yolk sac and yolk extension (Fig. 1 D -G, K-N) . After injection with MO1 between 80-90% of the larvae at 5-6 dpf showed these phenotypic abnormalities, while the effect of MO2 injection was lower, with only 5-10% of larvae displaying severe oedema and skin lesions ( Supplementary Fig. S1 C, D) . The heart beat frequency was unaffected in ptpn6 morphants until 4 dpf, but was approximately 40% reduced in larvae of 6 dpf, as the likely result of the increased cardiac oedema at this stage (data not shown). Morpholino injection of Tg(fli1:EGFP) embryos did not reveal defects in vascular development ( Supplementary Fig. S1 E-H).
Since mammalian ptpn6/shp1 has been implicated in negative regulation of growth factor, MAPK, and NF-κB signaling pathways, we investigated proliferation, apoptosis, and inflammation in ptpn6 morphants. Phosphohistone H3 immunolabeling revealed increased numbers of mitotic cells in ptpn6 morphants in a specific region on the dorsal side of the brain and in the retina at 5 dpf ( Fig. 3 A-D) . Furthermore, increased numbers of apoptotic cells were detected with a TUNEL assay, particularly in the brain and in the region of cardiac oedema at this stage ( Fig. 3 E-H) . To determine if the phenotype of the zebrafish ptpn6 morphants was associated with inflammation, we performed immunofluorescence staining using anti-L-plastin Ab, which stains all leukocytes (Mathias et al., 2007) . The results showed that leukocytes in 5 dpf ptpn6 morphants accumulated around the oedemic area of the heart cavity and at skin lesions, while they had largely disappeared from their normal location in the caudal hematopoietic tissue (Fig. 3 I-L ). In addition, we checked the expression of the proinflammatory genes il1b and mmp9. Quantitative RT-PCR (qPCR) showed that, concomitant with the appearance of the strong phenotypic defects at 5-6 dpf, the expression levels of il1b and mmp9 were enhanced in ptpn6 MO1 and MO2 morphant embryos compared to the controls at 5dpf and 6dpf, but not at 4dpf (Fig. 3 M-P) . We conclude, based on leukocyte infiltration and enhanced il1b and mmp9 expression, that the late pleiotropic phenotype of ptpn6 morphant larvae is associated with inflammation. 
The ptpn6 morphant phenotype is independent of the presence of microbes
Since inflammation might be triggered by the presence of microbes, we investigated whether the zebrafish ptpn6 morphant phenotype also developed in a germ-free environment. To this end, eggs were bleached, treated with iodine, and cultured in the presence of antibiotic and antifungal compounds following established protocols (Pham et al., 2008) . At the end of the experiment sterility was confirmed by plating culture medium on tryptic soy agar plates, showing that bacterial colonies developed from conventionally reared larvae but not from germ-free cultured larvae. When reared in the germ-free environment, 80-90% of the ptpn6 morphant larvae developed oedema and skin lesions, similar to the conventionally raised morphant larvae. Therefore, the inflammation-associated phenotype of ptpn6 morphants is apparently not driven by the presence of culturable microbes. RNA was isolated at 4-6 dpf from pools of 10-20 larvae, which were picked randomly in the case of con and MO1 morpholino injections. In the case of MO2, which has a lower penetrance, 10-20 larvae showing the oedema and skin lesion phenotype were selected. Gene expression levels of il1b (M, N) and mmp9 (O,P) were determined by qPCR and relative expression levels are shown with the lowest expression level set at 1. Data are the mean ± SEM of three independent experiments. Asterisks indicate significant differences (**, P < 0.01; ***, P <0.001) tested with an unpaired t-test.
Glucocorticoid treatment enhances the ptpn6 morphant phenotype
The immunosuppressive action of glucocorticoids is known to be conserved between zebrafish and mammals (Schaaf et al., 2009) . Since the ptpn6 morphant phenotype was associated with enhanced pro-inflammatory gene expression and leukocyte infiltration of affected tissues, we tested whether these effects could be suppressed by glucocorticoid treatment. Surprisingly, treatment with the synthetic glucocorticoid betamethasone 17-valerate, which was previously demonstrated to act as a potent glucocorticoid in zebrafish (Schoonheim et al., 2010) , enhanced rather than suppressed the development of oedema and skin lesions in ptpn6 morphants. Treatment with two other glucocorticoids, beclomethasone and prednisolone, also enhanced the development of oedema and skin lesions (data not shown). The affected tissues in morphants treated with betamethasone 17-valerate were accompanied by a more abundant leukocyte infiltration, as demonstrated using a transgenic marker line for neutrophils (Tg(mpx:gfp)i114, (Renshaw et al., 2006) and by L-plastin-immunostaining of neutrophils and macrophages (Fig. 4 A-F) . In addition, approximately 10% of ptpn6 morphants that were treated with betamethasone 17-valerate from 1 dpf died at 5 dpf, while all untreated morphants were viable until 7-8 dpf. In line with the enhanced phenotype, the induction levels of il1b and mmp9 were also further increased in morphants treated with betamethasone 17-valerate as compared to the control group (Fig. 4 G, H) . The increase of il1b and mmp9 at 5 dpf was more pronounced when betamethasone 17-valerate treatment was performed for 4 days starting at 1 dpf compared to a 2-day treatment starting at 3 dpf (Fig. 4 G, H) . However, no general insensitivity to glucocorticoids was observed. Expression of fkbp5, a well-known glucocorticoid receptor target gene (Schaaf et al., 2009) , was inducible by betamethasone 17-valerate in both ptpn6 morphants and control embryos (data not shown). In addition, betamethasone 17-valerate could still repress the expression of the pomc gene in the anterior lobe of the pituitary gland of ptpn6 morphants (Fig. 4 I-T) , a phenotype often used to score for glucocorticoid responsiveness (Schoonheim et al., 2010) . Overall, these results show that glucocorticoids are not able to suppress the inflammatory response observed in ptpn6 morphants, and that instead they unexpectedly enhance this response. neutrophil marker line were injected with standard control (con) or ptpn6 morpholino (MO1) and treated at 1 dpf with 1 μM betamethasone 17-valerate (BV) in 0.1% DMSO or with 0.1% DMSO alone as a control. Immunolabelling with Ab against the general leukocyte marker Lplastin was performed at 3 and 5 dpf. Confocal Z-stacks (fluorescence and transmission overlay) of the larval heads (lateral view, anterior to the left) are representative examples of ≥ 20 larvae in each group. Accumulation of leukocytes around sites of cardiac oedema and skin lesions in ptpn6 morphants is indicated with arrows and arrowheads, respectively. (G,H) Embryos were injected with standard control or ptpn6 (MO1) morpholino and treated with betamethasone 17-valerate (BV) for 2 days starting at 3 dpf or for 4 days starting at 1 dpf. RNA was isolated at 5 dpf from pools of 10-20 larvae. Gene expression levels of il1b (G) and mmp9 (H) were determined by qPCR and are represented as the fold increase of expression level of the MO1 group relative to that of the control morpholino group. Data are the mean ± SEM of three independent experiments. Asterisks indicate significant differences (* , P < 0.05; **, P <0.01) tested by two-way ANOVA analysis with Bonferroni method as post-hoc test. (I-T) Glucocorticoid repression of pomc expression in the anterior lobe of the pituitary gland in ptpn6 morphants and control embryos. Double transgenic zebrafish embryos expressing prolactin:rfp in the anterior lobe of the pituitary gland and pomc:gfp in the anterior and posterior lobes (Tg(-1.0pomca:GFP)zf44;Tg(prl:RFP)zf113, Liu et al., 2006) were injected with standard control (con, I-N) or ptpn6 (MO1, O-T) morpholinos and treated from 1 dpf with 1 μM betamethasone 17-valerate ( BV) in 0.1% DMSO (L-N, R-T) or with 0.1% DMSO as a control (I-K, O-Q). The pituitary gland was imaged at 5 dpf and confocal Z-stacks are representative of 15-20 embryos per group. In ptpn6 morphants the pituitary gland is twisted to the right compared to that in control embryos, but pomc:gfp expression in the anterior lobe is down-regulated by glucocorticoid treatment similar as it is in the control embryos.
Knockdown of ptpn6 impairs the ability of embryos to combat S. typhimurium and M. marinum infections
To investigate the function of ptpn6 in the innate immune response to infection, we challenged ptpn6 morphants and control embryos by intravenous injection of S. typhimurium bacteria. Importantly, bacterial injections were performed at 28 hpf, i.e. several days before the appearance of inflammation and other phenotypic effects in ptpn6 morphants. In both ptpn6 MO1 morphants and controls, S. typhimurium infection was lethal around 24-30 hours post infection (hpi). However, CFU counts at 2, 8 and 20 hpi showed that S. typhimurium proliferated faster in the ptpn6 morphants (Fig. 5 A) . Subsequently, we performed infections with the non-pathogenic S. typhimurium LPS OAg mutant strain Ra (van der Sar et al., 2003) . While this Ra strain hardly proliferated in control embryos, clear proliferation of the DsRed-labeled Ra bacteria was observed in approximately 55% of ptpn6 MO1 morphants at 1 day post infection (Fig. 5 B-D) . At 5 days post infection (dpi), control embryos had cleared the infection or showed very low DsRed fluorescence signal, while the majority of ptpn6 morphants were heavily infected or had died at 5 dpi (Fig. 5 B, E, F) . Increased proliferation of wild type and Ra S. typhimurium bacteria was also observed in embryos injected with ptpn6 MO2 ( Supplementary Fig. S1 I-L).
Next we examined the response of ptpn6 morphants to infection with M. marinum, a pathogen known to cause a chronic infection in zebrafish embryos, whereby infected and uninfected macrophages cluster into aggregates that resemble tuberculous granulomas (Davis et al., 2002; van der Sar et al., 2009) . At 3 dpi ptpn6 morphants showed increased fluorescence signal of mCherry labeled M. marinum bacteria and increased numbers of granuloma-like aggregates compared to control embryos . At 4 and 5 dpi, granulomas in ptpn6 morphants further increased in size compared to those in control embryos (Fig. 5 G, J-M) . Furthermore, immunohistochemical analysis using an L-plastin Ab of granulomas at 4 dpi showed that the bacteria were mostly extracellular in ptpn6 morphants, while in control embryos bacteria were mostly contained within L-plastin-labeled leukocytes (Fig. 5 N-Q) . In conclusion, when challenged with bacteria during early development, prior to the manifestation of the late inflammation-associated phenotype, ptpn6 morphants were severely impaired in their ability to control the progression of infection. This impaired control was observed with S. typhimurium and M. marinum strains that induce very different pathologies, indicating a general inability of ptpn6 morphants to mount a functional immune response.
Bacterial challenge of ptpn6 morphants leads to hyperinduction of il1b and mmp9 gene expression
To further investigate the function of ptpn6 in the innate immune response to infection, we performed qPCR analysis for two genes, il1b and mmp9, which were previously shown to represent robust pro-inflammatory markers associated with bacterial infection (Stockhammer et al., 2009 ) and with the late phenotype observed after ptpn6 knockdown (see above). We chose to analyze the response to S. typhimurium infection at 8 hpi (36 hpf) based on a previous time-course analysis (Stockhammer et al., 2009) . As expected, control embryos showed a strong induction of il1b and mmp9 expression levels. Upon knockdown of ptpn6 with MO1 or MO2, the induction levels of il1b and mmp9 were significantly higher than in the control embryos (Fig. 6 A, B) . Therefore, we conclude that ptpn6 functions as a negative regulator of il1b and mmp9 induction during S. typhimurium infection. Unlike the strong pro-inflammatory gene expression that is induced by S. typhimurium infection at 8 hpi (Fig. 6 A, B) , control embryos or ptpn6 morphants infected with M. marinum did not show significant il1b and mmp9 induction at this time point (Fig. 6 C, D) . However, at 3 dpi mmp9 (but not il1b) expression was increased in M. marinum-infected ptpn6 morphants compared to uninfected morphants and infected controls (Fig. 6 C, D) . In summary, a hyperinduction of pro-inflammatory genes was observed upon bacterial infections of ptpn6 morphants, yet their ability to control these infections was impaired. and ptpn6 morphants (MO1 and MO2). Embryos were injected at the 1-2 cell stage with standard control (con) or ptpn6 (MO1 or MO2) morpholinos, injected with PBS or with 250 CFU of S. typhimurium at 28 hpf, and RNA was isolated at 8 hpi for qPCR analysis. Relative expression levels are shown with the lowest expression level set at 1. Values are the means ± SEM of three biological replicates. (C, D) Gene expression levels of il1b (C) and mmp9 (D) in response to M. marinum infection. Embryos were injected with standard control morpholino (con) or ptpn6 MO1, approximately 100 CFU of M. marinum bacteria were injected at 28 hpf, and RNA was isolated at 8 hpi or 3 dpi. Relative expression levels are shown with the lowest expression level set at 1. Data are plotted on a logarithmic scale and are the mean ± SEM of three replicate experiments. Asterisks indicate significant differences (*, P < 0.05; **, P <0.01; ***, P <0.001) tested by two-way ANOVA analysis with Bonferroni method as post-hoc test. 
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Microarray analysis demonstrates an overall enhancement of the innate immune response to S. typhimurium infection upon ptpn6 knockdown
The S. typhimurium infection model was chosen for further investigation of the specific effects of ptpn6 knockdown on the innate immune response by microarray analysis. The advantage of this model for functional analysis of ptpn6 was that the response to S. typhimurium infection can be analyzed at 36 hpf (8 hpi) (Stockhammer et al., 2009; Ordas et al., 2011) , thus avoiding that the microarray analysis is affected by secondary effects of the late inflammatory phenotype (observed at 4-6 dpf). RNA samples from infected and mock-injected ptpn6 MO1 morphants or control embryos from three replicate experiments were analyzed using a common reference approach (Fig. 7 A) . First we analyzed the basal expression differences between mock-injected ptpn6 morphants and control embryos. KEGG pathway analysis showed that p53 signaling and cell cycle were the most significantly affected pathways, and minor effects were observed on cytosolic DNA-sensing, sucrose metabolism and pyrimidine metabolism (Fig. 7 B) . There was little overlap with the genes that were induced by infection in ptpn6 morphants: only 7% of the microarray probes that showed basal expression differences between controls and ptpn6 morphants were responsive to infection in ptpn6 morphants (Fig. 7 B) . The infection-responsive gene set showed significant alteration of many KEGG pathways related to the immune response, such as TLR, NLR, RIG-I, p53, MAPK, and JAK-STAT signaling (Fig. 7 B) . For further analysis of ptpn6 function we concentrated on the differences between the responses to infection in ptpn6 morphants and controls. The total number of probes showing significant responsiveness to infection was approximately 2-fold larger in ptpn6 morphants than in controls (Fig. 7 C) . Furthermore, the absolute fold changes of many infection-responsive probes were larger in ptpn6 morphants (see Supplementary Table 1 for a complete overview of the microarray data). In fact, a total of 598 probes (representing 258 different genes) showed significantly higher up-regulation in ptpn6 morphants and 78 probes (representing 51 different genes) showed significantly stronger down-regulation (Fig.  8) . Analysis of the gene group with higher up-regulation in ptpn6 morphants showed significant overrepresentation of TLR, NLR, RIG-I, p53, MAPK, JAK-STAT and other immune-related KEGG pathways (Fig. 7 C) . More specifically, genes showing higher upregulation in ptpn6 morphants included cytokine/chemokine/interferon genes such as il1b, il8, tnfa, tnfb, and ifnphi1, matrix metalloproteinases such as mmp9 and mmp13, and many transcriptional regulators of the ATF, CEBP, AP1, NFκB, and STAT families (Fig. 8) . The higher up-regulation of il1b and mmp9 was consistent with the qPCR experiments described above (Fig. 6 A, B) and with qPCR validation of the samples used for the microarray study ( Supplementary Fig. S2 A, B) . As observed in previous S. typhimurium infection studies, several negative regulators of immunity signaling are induced concomitantly with the induction of pro-inflammatory genes (Stockhammer et al., 2009; Ordas et al., 2011) . Similar to the increased induction of pro-inflammatory genes, infected ptpn6 morphants also showed increased induction levels of several of these negative regulators, such as irak3, socs3a and socs3b, and NFκB inhibitor genes (nfkbiaa, nfkbiab, nfkbib, nfkbiz 
Figure 7. Enhanced innate immune response to S. typhimurium in ptpn6 morphants. (A)
Experimental set-up of the microarray analysis. Embryos were injected with ptpn6 MO1 or Danieau's buffer at the 1-2 cell stage, and approximately 250 CFU of S. typhimurium bacteria were injected into the caudal vein at 28 hpf after the onset of the blood circulation, or PBS was injected as a control. Microarray analysis was performed on RNA samples extracted from pools of 15-20 embryos at 8 hpi. RNA samples from the four treatment groups (control/PBS, control/S. typhimurium, ptpn6 MO1/PBS, ptpn6 MO1/S. typhimurium) were obtained from three independent experiments and hybridized against a common reference consisting of RNA from all treatment groups. Next, four expression ratios were derived by Rosetta Resolver re-ratio analysis of the sample data against the common reference. The significance cut-offs were set an absolute fold change ≥1.5 and P ≤ 0. The smaller gene group that showed stronger down-regulation upon infection in ptpn6 morphants than in the controls included two CCL chemokine genes (ccl1 and cclc11a) and several leukocyte markers such as coro1a, cpa5, cxcr3.2, lgals9l1, lcp1, lyz, and mpx (Fig. 8) . However, there was no generally enhanced down-regulation of leukocyte markers in infected ptpn6 morphants, as mpeg1 was less repressed in infected ptpn6 morphants than in infected controls, and csf1r and mfap4 showed unaltered expression under all conditions. qPCR analysis of leukocyte markers showed the same trend as the microarray data, particularly increased down-regulation of lgals9l1, lyz, and mpx during infection, less pronounced down-regulation of mpeg1, and unaltered expression of other markers, including csf1r and mfap4 ( Supplementary Fig.  S2 C-F) . In conclusion, microarray analysis indicated that under ptpn6 knockdown conditions, embryos responded to S. typhimurium infection by an enhanced gene induction profile of the innate immune response.
Increased pro-inflammatory gene induction in S. typhimuriuminfected ptpn6 morphants is confirmed by RT-MLPA analysis
In addition to the microarray analysis, we used a recently described RT-MLPA assay that allows the simultaneous semi-quantitative PCR analysis of 34 innate immune genes (Rotman et al., 2011) . Further confirming the microarray results, RT-MLPA analysis showed over 2-fold increased S. typhimurium-induced up-regulation in ptpn6 morphants compared to controls for several cytokine/chemokine/interferon genes (cclc5a, cxcl-c1c, ifnphi1, il1b, il8 , and tnfa), immune-related transcription factor genes (fos, jun, junb, nfkb2, and rel) , the matrix metalloproteinase gene, mmp9, and the acidic chitinase gene, chia.6 (Fig. 9) . Additionally, five other genes that did not meet the significance thresholds in the microarray analysis (ccl20, ccl-c24i, cxc46, fkbp5, tlr5a ) also showed over 2-fold higher up-regulation in ptpn6 morphants based on RT-MLPA (Fig. 9) . Of note, in both microarray and RT-MLPA analysis, the anti-inflammatory il10 gene showed equal induction levels during S. typhimurium infection of ptpn6 morphants and controls (Fig. 9, Supplementary Table 1) . Based on the increased pro-inflammatory gene induction profile of S. typhimurium-infected ptpn6 morphants, observed in microarray analysis and RT-MLPA, we conclude that ptpn6 functions as a negative regulator of the innate immune response upon infection.
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Discussion
The association of SHP1/PTPN6 deficiency with several types of chronic inflammatory disorders and with lymphoid and myeloid malignancies has raised substantial interest in this hematopoietic phosphatase as a drug target (Kundu et al., 2010) . Here we exploited the zebrafish embryo as a novel animal model for studies on the function of the ptpn6 gene. The late onset of adaptive immunity during zebrafish development permits studying ptpn6 function in the sole context of innate immunity during embryo and larval development. Our results show that ptpn6 deficiency in this model leads to pleiotropic defects at the late larval stage, accompanied by leukocyte infiltration and up-regulated inflammatory gene expression. Moreover, when embryos were challenged with bacteria during earlier stages of development, ptpn6 knockdown enhanced the innate immune response to this infection. Despite this increased inflammatory response, ptpn6-deficient embryos were severely impaired in their ability to control infections, indicating the crucial importance of negative regulation by ptpn6 for a balanced and functional innate immune response.
Inflammation-associated effects of ptpn6 deficiency
Under normal culture conditions, without challenge by infection, ptpn6 morphant larvae developed severe oedema and skin lesions by 5 to 6 days of age. The affected tissues in zebrafish ptpn6 morphants were strongly infiltrated by leukocytes and increased numbers of TUNEL-positive apoptotic cells were also detected in these areas. Simultaneously, the overall expression levels of pro-inflammatory markers il1b and mmp9 were over 10-fold increased. The observed inflammation in zebrafish ptpn6 morphants is consistent with the function of mammalian SHP1 as a negative regulator of cytokine signaling, and is most likely caused by increased cytokine excretion by leukocytes which have been shown to exclusively express ptpn6 . It remains unknown whether inflammation is the primary cause or the consequence of oedema and skin lesions in ptpn6 morphants. The observed phenotype is highly reminiscent of the severe skin inflammation observed in murine Ptpn6 mutants, me, mev, and spin (Shultz et al., 1993; Tsui et al., 1993; Croker et al., 2008) . In mice, Ptpn6 deficiency, besides causing inflammation, was also associated with hyperproliferation of immune cells (Van Zant and Shultz, 1989 ), but we did not detect enhanced proliferation of myeloid cells during zebrafish embryonic and larval development. Among the three mutant alleles of Ptpn6 in mice, spin causes the least severe functional knockdown (Croker et al., 2008) . Inflammatory foot lesions of spin mutants did not develop when homozygotes were raised in a germfree environment, showing the requirement of the normal microbiota to trigger this phenotype (Croker et al., 2008) . However, me homozygotes born into a specific pathogen-free colony survived no better than under conventional conditions (Lutzner and Hansen, 1976) . Similarly, we found that the late inflammation-associated phenotype of ptpn6 morphant zebrafish larvae was equally severe when cultured using an established protocol to generate germ-free conditions (Pham et al., 2008) . Complete germ-free conditions cannot be guaranteed during morpholino injections, but at least a major reduction of microbes was achieved in our experiments, since no bacterial colonies were observed when the culture medium of morpholino-injected larvae was plated on rich culture medium. Therefore, like in the me mutant, most likely another mechanism than the response to microbes is responsible for the development of spontaneous inflammation in ptpn6 morphants.
In addition to the general inflammation-associated defects in ptpn6 morphants, the dorsal area of the brain contained increased numbers of apoptotic cells as well as increased numbers of cells positive for the proliferation marker phosphohistone H3. Deregulation of pathways such as MAPK and NF-κB signaling, known to be affected by mammalian SHP1, may explain enhanced proliferation and apoptotic cell numbers in ptpn6 morphants. The expression of ptpn6 in wild type embryos and larvae by whole mount in situ hybridization was only detectable in myeloid cells and in the larval thymus . However, it cannot be excluded that ptpn6 is also expressed in other tissues at lower levels, which may explain the specific hyperproliferative area in the brain of ptpn6 morphants. In rodents, Ptpn6 expression is also predominantly hematopoietic, but has been detected in other tissues as well, including the CNS (Massa et al., 2000; Horvat et al., 2001) .
Treatment with glucocorticoids enhanced the inflammatory phenotype, which is surprising since glucocorticoids are well known for their anti-inflammatory effects. They are widely used clinically to treat a variety of human immune-related diseases (Barnes, 2006) and their immune-suppressive effects appear to be well conserved between mammals and fish (Schaaf et al., 2009) . Most anti-inflammatory effects of glucocorticoids are a result of the inhibitory interaction between the glucocorticoid receptor (GR) and transcription factors like AP-1 and NF-κB which are important for the up-regulation of many pro-inflammatory genes (De Bosscher and Haegeman, 2009) . However, interaction with other transcription factors can enhance the activity of these proteins, and this may even lead to specific pro-inflammatory effects of glucocorticoids. In particular, interactions between GR and members of the STAT family, like STAT3, -5, and -6 have been demonstrated to be synergistic in nature (Zhang et al., 1997; Biola et al., 2000; Hermoso et al., 2004; Stoecklin et al., 1997; Rogatsky and Ivashkiv, 2006; Engblom et al., 2007) . Interestingly, the JAK/STAT signaling pathway has been shown to be negatively regulated by SHP1 in many studies (Valentino and Pierre, 2006) . Thus, the enhancement of the inflammatory phenotype upon ptpn6 knockdown in zebrafish by glucocorticoids might be explained by a synergistic interaction between the GR and transcription factors, like the members of the STAT family, that have become activated due to the Ptpn6 deficiency (Fig. 10) . Since in humans SHP1/PTPN6 deficiency has been shown to be possibly involved in the pathogenesis of several immune-related diseases, care should be taken when patients suffering from these diseases are treated with glucocorticoids. The SHP1 deficiency could be the cause of resistance to glucocorticoid treatment that is observed in a significant subpopulation of patients (Barnes and Adcock, 2009 ) and could theoretically even underlie a worsening of the disease state in response to this therapy.
Function of ptpn6 in the response to bacterial infections
Knockdown of ptpn6 impaired the ability of zebrafish embryos to control the proliferation of two bacterial pathogens that induce very different disease pathologies in the zebrafish embryo model: S. typhimurium, which causes acute disease, and M. marinum, which causes a chronic disease where bacteria persist in granulomatous aggregates. Even the growth of a normally non-pathogenic strain (S. typhimurium LPS O-Ag Ra mutant) could not be efficiently controlled and caused lethality. In contrast, murine spin mutants displayed increased resistance to Listeria monocytogenes (Croker et al., 2008) . As discussed above, the spin phenotype is ascribed to a hypomorphic allele of Ptpn6, which may explain why this mutant is immunocompetent while zebrafish ptpn6 morphants are not. The immunodeficiency of ptpn6 morphants was apparent at early developmental stages well before the spontaneous increase in basal levels of proinflammatory genes and developmental defects that occur later during larval development. We found that the expression levels of immune-related transcription factor genes and many effector genes of the innate immune response were hyperinduced upon infection in ptpn6 morphants. In agreement, the whole set of hyperinduced genes showed significant enrichment of KEGG pathways related to pathogen recognition and cytokine signaling. These results support the function of ptpn6 as a negative regulator of the innate immune response to bacterial infection. Since ptpn6 morphants displayed decreased resistance, the hyperactivation of their innate immune response is apparently contra-productive for the organism's defense against bacterial pathogens.
The hyperinduction of innate immune response genes upon infection of ptpn6 morphants was specific, since for example the expression levels of several myeloid markers were unchanged or reduced. In addition to many pro-inflammatory cytokines and transcription activators of the immune response, we also observed hyperinduction of other negative regulators than ptpn6 itself. Apparently, in the absence of ptpn6, increased induction of other negative regulators was insufficient to prevent excessive inflammation and a contra-productive defense response against bacterial pathogens. This may be explained by the presumed inhibitory effect of Ptpn6 on many cytokine and immuno-receptors as well as central kinases in innate immunity signaling pathways (Abu-Dayyeh et al., 2008; Abu-Dayyeh et al., 2010) , (Fig. 10) . Furthermore, the antiinflammatory cytokine gene il10 was not induced to higher levels in infected ptpn6 morphants than in controls. The fact that increased production of pro-inflammatory cytokines is not counteracted in ptpn6 morphants by increased anti-inflammatory IL10 production is a possible explanation for their non-functional immune response against bacterial pathogens. Table 2 ). Under conditions of PTPN6 deficiency the activation of transcriptional regulations like NFκB, AP-1 and STATs is enhanced (green arrows). Upon stimulation with glucocorticoids, the GR inhibits NF κB and AP-1 activity, but may have a synergistic interaction with STATs. Interestingly, virulence factors of Leishmania parasites have been proposed to block macrophage functions by activation of SHP1 (Abu-Dayyeh et al., 2008; Gomez et al., 2009) . Similarly, SHP1 activation by lipoarabinomannan (ManLAM) has been suggested as a host evasion strategy of Mycobacterium tuberculosis (Knutson et al., 1998; Rajos et al., 2002) . Our results show the important regulatory function of this phosphatase in the host innate immune response to bacterial pathogens, which therefore could indeed be an attractive target for bacteria to manipulate. In our study, deficiency of ptpn6 favored growth of S. typhimurium and M. marinum despite an enhanced innate immune response to these pathogens. These results are in line with studies of zebrafish embryos defective in TNF signaling or eicosanoid biosynthesis, which indicated that the outcome of M. marinum infection is worsened either when the fish produce high levels of anti-inflammatory lipoxins inhibiting TNF production, or when the fish produce pro-inflammatory leukotrienes and excessive levels of TNF (Clay et al., 2008; Tobin et al., 2010; Tobin et al., 2012) . We have shown that the role of ptpn6 is crucial for tightly regulating the induction levels of many key players in the innate immune response, identified by our microarray analysis, and conclude that the loss of ptpn6 function results in a non-functional immune response to S. typhimurium and M. marinum infections. (MO1) is indicated in red. This sequence comprises the phosphatase catalytic domain. We note that the ptpn6 genomic sequence on chromosome 16 in Ensembl Zv9 is erroneously split over two genes, ENSDARG00000089043, comprising coding exons 1-7, and ENSDARG00000013916, comprising coding exons 8-16. (B) Efficiency of the splice blocking morpholino. Embryos were injected at the 1-2 cell stage with Danieau's buffer (-) or with 1 nl of 0.06 mM ptpn6 MO1 in Danieau's buffer (+) and RNA was isolated at 1 and 5 dpf. RT-PCR with forward primer in coding exon 8 (ATATTCAGAGCAGAGTAAATCAG) and reverse primer in exon 13 (TTCGTCACCTTCGTTTCC) results in a 698 bp product for the intact mRNA and a 563 bp product when exon 12 is skipped due to MO1 knockdown. MO1 knockdown of the intact mRNA is near complete at 1 dpf and partial at 5 dpf. SL, size ladder. (C) Phenotype of 5 dpf larva injected with standard control morpholino (con). (D). Phenotype of 5 dpf larva injected with translation blocking morpholino (MO2). In different experiments 5-10% of MO2-injected larvae showed cardiac oedema (arrow) and skin lesions (arrowheads) similar as observed with MO1 (Fig.1) . (E-H) Fli1:EGFP embryos were injected with standard control mo (con, E,G) or ptpn6 MO1 (F,H), Representative fluorescence images (lateral view, anterior to the left) were taken at 2 dpf (E, F) and 6 dpf (G, H). (I-L) Phenocopy of the S. typhimurium infection phenotype with a translation blocking morpholino (MO2). (I). Infection with S. typhimurium wild type strain. Embryos were injected with standard control morpholino (con) or ptpn6 MO2 and infected with S. typhimurium at 28 hpf. Groups of 5 embryos were crushed in PBS at 2, 8, and 20 hpi, and dilutions were plated for CFU counting on LB medium with carbenicillin selection of the DsRED marker plasmid in S. typhimurium. A representative example of three independent experiments is shown. (J-L). Infection with S. typhimurium LPS mutant Ra strain. Embryos were injected with standard control morpholino (con) or ptpn6 MO2 and infected with S. typhimurium Ra at 28 hpf. The bacterial burden was analyzed at 1 dpi based on fluorescence of the DsRED marker plasmid. A quantification of phenotypes (J) and stereo fluorescence images (lateral view, anterior to the left) of 3 embryos per group (K, L) are shown for a representative example of three independent experiments. The bacterial burden in embryos at 1 dpi was scored as low (representative image in K) or high (representative image in L). 
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Supplementary Figure S2 . qPCR analysis of il1b, mmp9, and leukocyte-specific genes in ptpn6 morphants and control embryos infected with S. typhimurium. (A, B) Increased ilb (A) and mmp9 (B) induction in infected ptpn6 morphants compared to infected controls. (C-F) qPCR analysis of leukocyte-specific genes. qPCR analysis was performed on RNA samples from mock-injected (PBS) or S. typhimurium-infected (St) control embryos (con) and ptpn6 morphants (MO1). Relative expression levels are shown with the lowest expression level set at 1. Values are the means ± SEM of three independent sample sets, which were the same as previously used for microarray analysis. Asterisks in A and B indicate significant differences (**, P <0.01; **) tested by two-way ANOVA analysis with Bonferroni method as post-hoc test. Data for the leukocyte-specific genes were not significant by two-way ANOVA analysis and Bonferroni post-hoc test, but showed the same trend as the microarray data, i.e. stronger S. typhimurium-mediated down-regulation of lgals9l1, lyz and mpx show in ptpn6 morphants than in controls (C), less pronounced S. typhimurium-mediated down-regulation of mpeg1 in ptpn6 morphants than in controls (D), unchanged expression of cxcr3.2, csfr1, and mfap4 during S. typhimurium infection of ptpn6 morphants and controls (E), and S. typhimurium-inducible expression of MARCO receptor homolog LOC571584 and ncf1 in both ptpn6 morphants and controls (F). 
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